International Prospective Registry on Local Treatment Approaches in MLS
ConditionMyxoid Liposarcoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe Netherlands Cancer Institute
About this trial
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
Eligibility criteria
Qualifiers
Age > 18 years
Biopsy proven MLS, including the reciprocal chromosomal translocation t(12;16)(q13;p11)
ECOG PS 0-2
Written informed consent to share coded information in this international Registry
Disqualifiers
Prior radiotherapy to the target area
Pregnancy
Trial design
Treatments tested in this trial
- Surgery
- Preoperative RT 36Gy
- Preoperative RT 50Gy
- Postoperative RT 50-66Gy
- RT 36Gy
Treatment groups
300 Participants
are divided into 5 treatment groupsSponsors and collaborators
The Netherlands Cancer Institute
Lead sponsor
Radboud University Medical Center
Collaborator
Maastro Clinic, The Netherlands
Collaborator
University Medical Center Groningen
Collaborator
Leiden University Medical Center
Collaborator
Vienna General Hospital
Collaborator
M.D. Anderson Cancer Center
Collaborator
University Hospital, Antwerp
Collaborator
Universitetssykehus
Collaborator
Haukeland University Hospital
Collaborator
Universitäts-Frauenklinik Graz
Collaborator
University Hospital Heidelberg
Collaborator
Mayo Clinic
Collaborator
Aarhus University Hospital
Collaborator
National Cancer Center, Japan
Collaborator
Princess Margaret Hospital, Canada
Collaborator
MOUNT SINAI HOSPITAL
Collaborator
University of Sydney
Collaborator
Institute for Cancer Research and treatment
Collaborator
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Collaborator
Institut Curie
Collaborator
Australia and New Zealand Sarcoma Association
Collaborator
Source ClinicalTrials.gov